Extracellular cAMP-dependent protein kinase (ECPKA) in melanoma
- 28 May 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 208 (2) , 187-191
- https://doi.org/10.1016/j.canlet.2004.02.018
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Genetic epidemiology of melanomaEuropean Journal Of Cancer, 2003
- cAMP effector mechanisms. Novel twists for an ‘old’ signaling systemFEBS Letters, 2003
- Proteomics in translational cancer research: Toward an integrated approachCancer Cell, 2003
- Reinventing the Wheel of Cyclic AMPAnnals of the New York Academy of Sciences, 2002
- Cellular and molecular biology of human melanoma.Cancer Biology & Therapy, 2002
- Biochemical Characterization of Extracellular cAMP-Dependent Protein Kinase as a Tumor MarkerBiochemical and Biophysical Research Communications, 2000
- Extracellular protein kinase A as a cancer biomarker: Its expression by tumor cells and reversal by a myristate-lacking Cα and RIIβ subunit overexpressionProceedings of the National Academy of Sciences, 2000
- Molecular events in melanoma development and progressionFrontiers in Bioscience-Landmark, 1998
- Mg X ATP2-dependent interaction of the inhibitor protein of the cAMP-dependent protein kinase with the catalytic subunit.Published by Elsevier ,1983
- In vivo phosphorylation of a synthetic peptide substrate of cyclic AMP-dependent protein kinase.Proceedings of the National Academy of Sciences, 1978